The true prevalence of NAFLD is unknown, as it is the most common (approximately 90%) cause of asymptomatic aspartate aminotransferase (AST) and alanine aminotransferase (ALT) elevation in patients presenting to clinics, and the majority of cases are asymptomatic [1]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.